Article
Association of Mutant KRAS Alleles With Morphology and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.
Archives of pathology & laboratory medicine - 1 Dec 2024
Chao Timothy, Wang Zi-Xuan, Bowne Wilbur B, Yudkoff Clifford J, Torjani Ava, Swaminathan Vishal, Kavanagh Taylor R, Roadarmel Austin, Sholevar Cyrus J, Cannaday Shawnna, Krampitz Geoffrey, Zhan Tingting, Gorgov Eliyahu, Nevler Avinoam, Lavu Harish, Yeo Charles J, Peiper Stephen C, Jiang Wei
Abstract excerpt
CONTEXT.—: Mutant KRAS is the main oncogenic driver in pancreatic ductal adenocarcinomas (PDACs). However, the clinical and phenotypic implications of harboring different mutant KRAS alleles remain poorly understood. OBJECTIVE.—: To characterize the potential morphologic and clinical outcome differences in PDACs harboring distinct mutant KRAS alleles. DESIGN.—: Cohort 1 consisted of 127 primary conventional PDACs...
Topics
Join the communities discussing this publication.
